Sara Mangsbo, PhD

Professor at Uppsala University

Speaker

Sara is Professor in antibody/protein drugs at Uppsala University. She is also an entrepreneur, and founder of several companies including Immuneed AB and Strike Pharma AB. Her expertise is focused on developing and characterizing new modality drugs such as antibody and peptide-derived frameworks, her recent work led to the innovative Adaptable Drug Affinity Conjugate (ADAC) technology that can be used for targeted delivery of drugs within precision medicine. She has been part of developing drugs from the lab bench to clinical testing and has also been the active force behind the repurposing of the Chandler loop model to the ID.Flow as a tool for drug characterization. She has been rewarded Entrepreneur of the Year by Veckans Affärer and received Uppsala University's Hjärnäpplet innovation prize and the Biotech Builder Award.